Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea

BACKGROUND/AIMS: Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. However, there are no published data on the efficacy of antiviral therapy in Korea. We assessed the safety and efficacy of combination therapy with peginterferon α-2a plus ribavirin for CHC in hemophilia....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Mol Hepatol
Main Authors: Yang, Suh Yoon, Lee, Hyun Woong, Lee, Youn Jae, Park, Sung Jae, Yoo, Ki Young, Kim, Hyung Joon
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493355/
https://ncbi.nlm.nih.gov/pubmed/26157749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.21.2.125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados